These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6149951)

  • 1. [Lithium valproate: its neuropharmacological spectrum and effect on transmitter amino acid content of the brain of rats].
    Kharlamov AN; Shumkova OV; Blinkova NF; Tolmacheva NS; Raevskiĭ KS
    Farmakol Toksikol; 1984; 47(5):11-5. PubMed ID: 6149951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of sodium valproate on the mediator amino acid content in the rat brain].
    Kharlamov AN; Kovalev GI; Shumkova OV
    Farmakol Toksikol; 1982; 45(5):31-4. PubMed ID: 6128253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice.
    Swiader M; Wielosz M; Czuczwar SJ
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):307-18. PubMed ID: 15163441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate and myoclonus.
    Chapman AG
    Adv Neurol; 1986; 43():661-74. PubMed ID: 3080855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antiepileptic drugs on the cerebral amino acid uptake in vitro.
    Saladini M; Gabana MA; Bracco F; Zanchin G; Maggioni F; Battistin L
    Ital J Neurol Sci; 1981 Dec; 2(4):351-60. PubMed ID: 6120919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of stimulation of the gamma-aminobutyric acid shunt by valproate and E-delta 2-valproate in neonatal rat brain.
    Bolaños JP; Medina JM
    Mol Pharmacol; 1993 Mar; 43(3):487-90. PubMed ID: 8450838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant activity of 4,9-dioxo-5,10-diazatetradecane (CM 40142), a new GABA derivative, in mice and photosensitive baboons).
    Chambon JP; Molimard JC; Calassi R; Maruani J; Rodier D; Sigault G; Leyris R; Roncucci R; Bizière K
    Arzneimittelforschung; 1984; 34(9):1017-21. PubMed ID: 6439227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in regional brain levels of amino acid putative neurotransmitters after prolonged treatment with the anticonvulsant drugs diphenylhydantoin, phenobarbitone, sodium valproate, ethosuximide, and sulthiame in the rat.
    Patsalos PN; Lascelles PT
    J Neurochem; 1981 Feb; 36(2):688-95. PubMed ID: 6109766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin modulates the anticonvulsant effect of diazepam and sodium valproate in pentylenetetrazole and maximal electroshock induced seizures in mice.
    Srivastava AK; Gupta YK
    Indian J Physiol Pharmacol; 2001 Oct; 45(4):475-80. PubMed ID: 11883156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic lithium and sodium valproate on concentrations of brain amino acids.
    O'Donnell T; Rotzinger S; Ulrich M; Hanstock CC; Nakashima TT; Silverstone PH
    Eur Neuropsychopharmacol; 2003 Aug; 13(4):220-7. PubMed ID: 12888180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of sodium valproate and its metabolites (5-OH-VPA and 4-OH-VPA) on electroconvulsions in rats.
    Sobaniec W; Sobaniec-Lotowska M
    Mater Med Pol; 1994; 26(1):29-32. PubMed ID: 7808038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study of the neurotropic activity of lithium oxybutyrate].
    Liubimov BI; Tolmacheva NS; Ostrovskaia RU; Mitrofanov VS
    Farmakol Toksikol; 1980; 43(3):273-6. PubMed ID: 7449964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of sodium valproate on the central nervous system.
    Tunnicliff G
    J Physiol Pharmacol; 1999 Sep; 50(3):347-65. PubMed ID: 10574466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.
    Watson DG; Watterson JM; Lenox RH
    J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism by classical antiepileptics and sodium valproate of cefazolin in induced experimental epilepsy in rats.
    Nistico G; De Sarro GB; Rotiroti D; Silvestri R; Marmo E
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):429-44. PubMed ID: 6775359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relations between GABAergic and enkephalinergic systems: effects of sodium valproate on rat brain enkephalins.
    Vion-Dury J; Cupo A; Jarry T
    NIDA Res Monogr; 1986; 75():426-9. PubMed ID: 3123960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mood stabilizers: protecting the mood...protecting the brain.
    Brunello N
    J Affect Disord; 2004 Apr; 79 Suppl 1():S15-20. PubMed ID: 15121343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain.
    Löscher W
    Neurochem Res; 1993 Apr; 18(4):485-502. PubMed ID: 8097295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of lithium, carbamazepine, ca-valproate and diazepam on changes in social isolation-induced behavior in mice].
    Oehler J; Jähkel M; Schmidt J
    Biomed Biochim Acta; 1985; 44(10):1523-30. PubMed ID: 3936492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.